Replies to post #155750 on OWC Pharmaceutical Research Corp (OWCP)

[I-Glow]

The FDA has approved Epidiolex and the DEA classified it as a Schedule V drug.

Now GWP has to market the drug - which they spent tens of millions to develop and go through the FDA approved clinical trials.

IG